start come control soon administer vaccine preventing infection not key measure efficacy trials designed vaccines reduce hospital intensive care admissions death assurance vaccines work important high risk groups like elderly reside nursing homes nearly half deaths occurred fda works closely vaccine companies paid assessing vaccine candidates set low bar certifying effective halve risk mild covid symptoms like sore throat cough pfizer company receive eua says aced test declaring 95 percent efficacy journal article remain 44,000 people pfizer results based 170 confirmed cases know vaccine effectiveness 12 months despite fda advisory panel intense pressure quickly grant emergency use announced december 11